Pancreatic Cancer Research

ResearcherBuffalo BioLabsActive in the last 2 years

Katerina V. Gurova

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9189-0712; OpenAlex author ID A5015550222; NIH RePORTER profile ID 10614109. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 grant · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. Co-author DOI 10.1261/rna.079931.123↗
  2. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Last author DOI 10.18632/oncotarget.2701↗

Grants 1

  1. Testing of novel anti-cancer compounds Curaxins against pancreatic cancer R41CA159657↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Abigail C. Cornwell · 1 shared paper, 2024 · strength 0.18
  2. Swati Venkat · 1 shared paper, 2024 · strength 0.18
  3. Kathryn E. Maraszek · 1 shared paper, 2024 · strength 0.18
  4. Abdulrahman A. Alahmari · 1 shared paper, 2024 · strength 0.18
  5. Michael E. Feigin · 1 shared paper, 2024 · strength 0.18
  6. Laura A. Martello · 1 shared paper, 2014 · strength 0.04
  7. Catherine A. Burkhart · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.